{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:24:56Z","timestamp":1787754296318,"version":"build-2784847793"},"reference-count":18,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"unspecified","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2026,7,22]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Postictal psychosis (PIP) is a transient psychiatric phenomenon characterised by psychotic symptoms following a seizure. While its immediate manifestations have been well documented, there is limited understanding of its long-term implications, particularly its relationship with subsequent primary psychotic disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study using de-identified patient data from the TriNetX database (2006\u20132026). Individuals aged 18\u201365 years with a diagnosis of probable PIP (International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM): F06.0, F06.2) or brief psychotic disorder within 7\u2009days of the epileptic disorder diagnosis (ICD-10-CM: F23) were propensity-score matched 1:1 with controls without PIP based on age, sex, race, ethnicity and relevant psychiatric and chronic physical comorbidities. We excluded individuals with prior psychotic disorders or delirium. The primary outcome was any psychotic disorder diagnosis within a 5-year follow-up period. Kaplan-Meier survival analyses and HRs were calculated to assess the differences in survival probabilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 1275 individuals were identified and matched for analysis. Patients with probable PIP were at significantly higher risk for subsequent psychotic disorders (HR=10.78, 95%\u2009CI 6.21 to 18.70, p=0.002). The 5-year survival probability for developing any psychotic disorder was 85.79% in the probable PIP group compared with 98.21% in controls (log-rank test, \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      =112.25; p&lt;0.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Probable PIP is associated with a heightened risk of subsequent primary psychotic disorders, including interictal forms, within 5 years.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjno-2025-001473","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:25:23Z","timestamp":1787750723000},"page":"e001473","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Association between probable postictal psychosis and subsequent diagnosis of primary psychotic disorders: a retrospective cohort study"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5097-3375","authenticated-orcid":false,"given":"Varsha","family":"Nandwana","sequence":"first","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine, Virginia Tech Carilion School of Medicine, Roanoke, Virginia, USA"},{"name":"Carilion Clinic, Roanoke, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetika","family":"Bajpai","sequence":"additional","affiliation":[{"name":"Department of Neurology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Fang","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Medicine, University of Washington School of Medicine, Seattle, Washington, USA"},{"name":"Department of Psychiatry, Seattle Children\u2019s Hospital, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita S","family":"Kablinger","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Medicine, Virginia Tech Carilion School of Medicine, Roanoke, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aashit K","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine, Virginia Tech Carilion School of Medicine, Roanoke, Virginia, USA"},{"name":"Carilion Clinic, Roanoke, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"2026082606251530000_8.2.e001473.1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.yebeh.2016.03.022","article-title":"Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: A review of the evidence","volume":"61","author":"Kanner","year":"2016","journal-title":"Epilepsy & Behavior"},{"key":"2026082606251530000_8.2.e001473.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.01222.x"},{"key":"2026082606251530000_8.2.e001473.3","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.152.2.246"},{"key":"2026082606251530000_8.2.e001473.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1996.tb00608.x"},{"key":"2026082606251530000_8.2.e001473.5","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.3.325"},{"key":"2026082606251530000_8.2.e001473.6","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000874"},{"key":"2026082606251530000_8.2.e001473.7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-14-3"},{"key":"2026082606251530000_8.2.e001473.8","doi-asserted-by":"crossref","unstructured":"Gargiulo \u00c1JM , Sc\u00e9vola L , Sarudiansky M , et al . Epilepsy and psychiatric comorbidities: new approaches and perspectives. In: Psychiatry and neuroscience update: from epistemology to clinical psychiatry\u2013Vol IV. 2021: 537\u201353.","DOI":"10.1007\/978-3-030-61721-9_38"},{"key":"2026082606251530000_8.2.e001473.9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/09540261.2017.1302412","article-title":"Psychiatric comorbidities in epilepsy","volume":"29","author":"Josephson","year":"2017","journal-title":"Int Rev Psychiatry"},{"key":"2026082606251530000_8.2.e001473.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38488.462037.8F"},{"key":"2026082606251530000_8.2.e001473.11","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/S0140-6736(13)60899-5","article-title":"Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study","volume":"382","author":"Fazel","year":"2013","journal-title":"The Lancet"},{"key":"2026082606251530000_8.2.e001473.12","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2015.243"},{"key":"2026082606251530000_8.2.e001473.13","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/j.1528-1167.2007.01058.x","article-title":"Duration of postictal psychotic episodes","volume":"48","author":"Adachi","year":"2007","journal-title":"Epilepsia"},{"key":"2026082606251530000_8.2.e001473.14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2001.10701.x"},{"key":"2026082606251530000_8.2.e001473.15","doi-asserted-by":"publisher","DOI":"10.1177\/1756285612454180"},{"key":"2026082606251530000_8.2.e001473.16","first-page":"S2","article-title":"Behavioral, psychotic, and anxiety disorders in epilepsy: etiology, clinical features, and therapeutic implications","volume":"40 Suppl 10","author":"Torta","year":"1999","journal-title":"Epilepsia"},{"key":"2026082606251530000_8.2.e001473.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2012.01.011"},{"key":"2026082606251530000_8.2.e001473.18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1212\/CON.0000000000001123","article-title":"Neuropsychiatric and Cognitive Comorbidities in Epilepsy","volume":"28","author":"Mula","year":"2022","journal-title":"Continuum"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2025-001473","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:25:25Z","timestamp":1787750725000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2025-001473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":18,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,8,26]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/bmjno-2025-001473"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2025-001473","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}